| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.05B | -28.3% |
| Gross profit | ¥0.00B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 4.0% | Net margin -31.4% |
| Revenue Q/Q | -85.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.05B | 96.0% |
| R&D | ¥0.02B | 36.2% |
| SG&A | ¥0.01B | 28.7% |
| Tax & other | ¥-0.01B | -11.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
海波重科 ・ 新迅达 ・ 新光药业 ・ 科大国创 ・ 爱司凯 ・ 世名科技 ・ 辰安科技 ・ 博思软件 ・ ST应急 ・ 幸福蓝海 ・ 健帆生物 ・ 领湃科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies